Company intelligence / Profile preview
Bazelet Group
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
Overview
Bazelet Group is the largest medical cannabis company in Israel. It has developed 84 terpene-enriched cannabis oils approved by the Israeli Ministry of Health and serves thousands of patients monthly. The company operates a GMP facility and focuses on precision medicine through standardized cannabinoid/terpene formulations for diverse patient groups including those with Alzheimer’s disease/dementia and autism. Its products are available in all licensed pharmacies in Israel. The group is also active in R&D with multiple patent applications filed recently.
- Therapeutic areas
- OtherPsychiatryNeurology
- Modalities
- Plant-derived therapySmall molecule (cannabinoids and terpenes)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Bazelet Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bazelet Group.